Portfolio Matrix Analysis Of Pharmaceuticals Procurement: The Case Of Epsa
| dc.contributor.advisor | Ensermu, Matiwos(PhD) | |
| dc.contributor.author | Ayele, Shimelis | |
| dc.date.accessioned | 2020-12-16T06:43:13Z | |
| dc.date.accessioned | 2023-11-04T14:01:24Z | |
| dc.date.available | 2020-12-16T06:43:13Z | |
| dc.date.available | 2023-11-04T14:01:24Z | |
| dc.date.issued | 2020-06 | |
| dc.description.abstract | The objectives of this research areto assess the spend in the total expenditure, and supply risk (supplier availability rate) of regular medicines; to identify the category or position of each regular medicine according to: Leverage, Critical (strategic), Routine (non-critical), or Bottle neck items quadrant; and to assess tender processing periodat Ethiopian Pharmaceuticals Supply Agency (EPSA). The study used descriptive research design with quantitative research approach and documentary analysis of pure secondary data. The position of each regular medicine has been quantified empirically using secondary data from three years procurement record of the agency. Based on rigorous analysis of these data, 7.65% and 0.76% of the total items procured within these years have been found to fall in leverage and strategic item quadrant while 60.09% and 31.5% fell in non-critical and bottle neck quadrant of the matrix respectively. The finding on item category analysis indicates a profound problem of deviation from the typical item positioning feature which occurred because of the presence of least procured items and lack of suppliers for some number of items. The limitation of this study is that only the total FOB price and supplier availability rate of pharmaceuticals were taken as the basic variables to categorize items on the vertical and horizontal axes of Kraljic portfolio model. | en_US |
| dc.identifier.uri | http://etd.aau.edu.et/handle/123456789/24100 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Addis Ababa University | en_US |
| dc.subject | Procurement portfolio matrix | en_US |
| dc.subject | Pharmaceuticals procurement category | en_US |
| dc.subject | Pharmaceutical spends and supply risk | en_US |
| dc.title | Portfolio Matrix Analysis Of Pharmaceuticals Procurement: The Case Of Epsa | en_US |
| dc.type | Thesis | en_US |